• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大麻与心理健康:心理健康状况对大麻使用的不良后果和自我报告影响。

Cannabis and Mental Health: Adverse Outcomes and Self-Reported Impact of Cannabis Use by Mental Health Status.

机构信息

School of Public Health Sciences, University of Waterloo, ON, Canada.

Department of Psychology, Addiction and Mental Health Group (AIM), University of Bath, Bath, UK.

出版信息

Subst Use Misuse. 2022;57(5):719-729. doi: 10.1080/10826084.2022.2034872. Epub 2022 Feb 16.

DOI:10.1080/10826084.2022.2034872
PMID:35170396
Abstract

Cannabis can induce negative outcomes among consumers with mental health conditions. This study examined medical help-seeking behavior, patterns of adverse effects, and perceived impacts of cannabis among consumers with and without mental health conditions. Data came from the International Cannabis Policy Study, via online surveys conducted in 2018. Respondents included 6,413 past 12-month cannabis consumers aged 16-65, recruited from commercial panels in Canada and the US. Regression models examined differences in adverse health effects and perceived impact of cannabis among those with and without self-reported past 12-month experience of anxiety, depression, PTSD, bipolar disorder, psychosis. Overall, 7% of past 12-month consumers reported seeking medical help for adverse effects of cannabis, including panic, dizziness, nausea. Help-seeking was greater for those with psychosis (13.8%: AOR = 1.78; 1.11-2.87), depression (8.9%: AOR = 1.57; 1.28-1.93), and bipolar disorder (10.1%: AOR = 1.53; 1.44-2.74). Additionally, 54.1% reported using cannabis to manage symptoms of mental health, with higher rates among those with bipolar (90.8%) and PTSD (90.7%). Consumers reporting >1 condition were more likely to perceive positive impacts on friendships, physical/mental health, family life, work, studies, quality of life (all < .001). Consumers with psychosis were most likely to perceive negative effects across categories. For conditions with substantial evidence suggesting cannabis is harmful, greater help-seeking behaviors and self-perceived negative effects were observed. Consumers with mental health conditions generally perceive cannabis to have a positive impact on their lives. The relationship between cannabis and mental health is disorder specific and may include a combination of perceived benefits and harms.

摘要

大麻会给有心理健康问题的消费者带来负面影响。本研究调查了有心理健康问题和没有心理健康问题的消费者寻求医疗帮助的行为、不良反应模式以及对大麻的感知影响。数据来自国际大麻政策研究,通过 2018 年在加拿大和美国的商业小组进行的在线调查。受访者包括 6413 名过去 12 个月有大麻消费史的 16-65 岁消费者,他们是从商业小组招募的。回归模型比较了报告有和没有过去 12 个月焦虑、抑郁、创伤后应激障碍、双相情感障碍、精神病经历的消费者之间的不良反应和大麻感知影响的差异。总体而言,7%的过去 12 个月消费者因大麻的不良反应寻求医疗帮助,包括恐慌、头晕、恶心。精神病患者寻求帮助的比例更高(13.8%:AOR=1.78;1.11-2.87),抑郁(8.9%:AOR=1.57;1.28-1.93)和双相情感障碍(10.1%:AOR=1.53;1.44-2.74)。此外,54.1%的人报告说使用大麻来控制心理健康症状,双相情感障碍和创伤后应激障碍患者的这一比例更高(分别为 90.8%和 90.7%)。报告>1 种疾病的消费者更有可能认为大麻对友谊、身心健康、家庭生活、工作、学习、生活质量有积极影响(均<0.001)。患有精神病的消费者最有可能在各个类别中感知到负面影响。对于有大量证据表明大麻有害的疾病,观察到更多的寻求医疗帮助行为和自我感知的负面影响。一般来说,有心理健康问题的消费者认为大麻对他们的生活有积极影响。大麻和心理健康之间的关系是特定于疾病的,可能包括感知到的益处和危害的组合。

相似文献

1
Cannabis and Mental Health: Adverse Outcomes and Self-Reported Impact of Cannabis Use by Mental Health Status.大麻与心理健康:心理健康状况对大麻使用的不良后果和自我报告影响。
Subst Use Misuse. 2022;57(5):719-729. doi: 10.1080/10826084.2022.2034872. Epub 2022 Feb 16.
2
Cannabis and mental health: Prevalence of use and modes of cannabis administration by mental health status.大麻与心理健康:按心理健康状况划分的使用流行率和大麻使用方式。
Addict Behav. 2021 Oct;121:106991. doi: 10.1016/j.addbeh.2021.106991. Epub 2021 May 19.
3
Adverse outcomes of cannabis use in Canada, before and after legalisation of non-medical cannabis: cross-sectional analysis of the International Cannabis Policy Study.加拿大在非医用大麻合法化前后使用大麻的不良后果:国际大麻政策研究的横断面分析。
BMJ Open. 2024 Jan 3;14(1):e077908. doi: 10.1136/bmjopen-2023-077908.
4
Self-reported Impact of the COVID-19 Pandemic on Cannabis Use in Canada and the United States.新冠疫情对加拿大和美国大麻使用情况的自我报告影响
J Psychoactive Drugs. 2023 Sep-Oct;55(4):483-492. doi: 10.1080/02791072.2022.2110023. Epub 2022 Aug 18.
5
Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada.美国和加拿大医用大麻使用的流行情况和自我报告原因。
Psychopharmacology (Berl). 2022 May;239(5):1509-1519. doi: 10.1007/s00213-021-06047-8. Epub 2022 Jan 12.
6
A cross-sectional study of the relationship between frequency of cannabis use and psychiatric symptoms among people seeking mental health and addiction services in Nova Scotia (2019-21).一项在新斯科舍省寻求心理健康和成瘾服务的人群中进行的横断面研究,调查了大麻使用频率与精神症状之间的关系(2019-21 年)。
J Psychiatr Res. 2024 May;173:104-110. doi: 10.1016/j.jpsychires.2024.03.018. Epub 2024 Mar 18.
7
Mental Health and Medical Cannabis Use among Youth and Young Adults in Canada.加拿大青少年和年轻成年人的心理健康与医用大麻使用。
Subst Use Misuse. 2020;55(4):582-589. doi: 10.1080/10826084.2019.1691594. Epub 2019 Nov 20.
8
Use of cannabis for mental health in the Canadian territories: a cross-sectional study.加拿大各地区将大麻用于心理健康的情况:一项横断面研究。
Subst Use Misuse. 2025;60(1):74-82. doi: 10.1080/10826084.2024.2409711. Epub 2024 Sep 29.
9
Home cultivation across Canadian provinces after cannabis legalization.大麻合法化后加拿大各省的家庭种植情况。
Addict Behav Rep. 2022 Mar 25;15:100423. doi: 10.1016/j.abrep.2022.100423. eCollection 2022 Jun.
10
Consumer perceptions of legal cannabis products in Canada, 2019-2021: a repeat cross-sectional study.2019-2021 年加拿大消费者对合法大麻产品的认知:一项重复横断面研究。
BMC Public Health. 2022 Nov 8;22(1):2048. doi: 10.1186/s12889-022-14492-z.

引用本文的文献

1
Budtender Perceptions and Knowledge of Cannabis and Mental Health: A Preliminary Study.大麻销售助理对大麻与心理健康的认知:一项初步研究。
Cannabis. 2025 Jul 15;8(2):164-176. doi: 10.26828/cannabis/2025/000292. eCollection 2025.
2
The Complex Relationship Between Cannabis Use and Mental Health: Considering the Influence of Cannabis Use Patterns and Individual Factors.大麻使用与心理健康之间的复杂关系:考量大麻使用模式及个体因素的影响
CNS Drugs. 2025 Feb;39(2):113-125. doi: 10.1007/s40263-024-01148-2. Epub 2025 Jan 4.
3
Cannabis Consumption Among Adults Aged 55-65 in Canada, 2018-2021.
2018 - 2021年加拿大55 - 65岁成年人的大麻消费情况
J Drug Issues. 2025 Jan;55(1):33-49. doi: 10.1177/00220426231190022. Epub 2023 Jul 19.
4
Health concerns, access to care, and trust in research and researchers among community members with bipolar disorder.双相情感障碍社区成员的健康问题、医疗服务可及性以及对研究和研究人员的信任。
Discov Ment Health. 2024 Sep 10;4(1):34. doi: 10.1007/s44192-024-00091-4.
5
Assessing rates and predictors of cannabis-associated psychotic symptoms across observational, experimental and medical research.评估观察性、实验性和医学研究中与大麻相关的精神病症状的发生率及预测因素。
Nat Ment Health. 2024;2(7):865-876. doi: 10.1038/s44220-024-00261-x. Epub 2024 Jun 3.
6
Threaten, Distract, and Discredit: Cannabis Industry Rhetoric to Defeat Regulation of High-THC Cannabis Products in Washington State.威胁、转移注意力和诋毁:为了挫败华盛顿州对高 THC 大麻产品的监管,大麻产业的言论策略。
J Stud Alcohol Drugs. 2024 May;85(3):322-329. doi: 10.15288/jsad.23-00277. Epub 2024 Jan 25.
7
Eight Weeks of Daily Cannabidiol Supplementation Improves Sleep Quality and Immune Cell Cytotoxicity.每日补充大麻二酚 8 周可改善睡眠质量和免疫细胞细胞毒性。
Nutrients. 2023 Sep 27;15(19):4173. doi: 10.3390/nu15194173.
8
Perceptions of cannabis use risk to mental health among youth in Canada, England and the United States from 2017 to 2021.2017 年至 2021 年期间加拿大、英国和美国青少年对大麻使用风险的认知与心理健康。
Drug Alcohol Depend. 2023 Sep 1;250:110904. doi: 10.1016/j.drugalcdep.2023.110904. Epub 2023 Jul 22.
9
Avatar Intervention for Cannabis Use Disorder in Individuals with Severe Mental Disorders: A Pilot Study.针对重度精神障碍患者大麻使用障碍的阿凡达干预:一项试点研究。
J Pers Med. 2023 Apr 29;13(5):766. doi: 10.3390/jpm13050766.